The development of atypical hemolytic uremic syndrome is not influenced by thrombophilia susceptibility factors.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 16102133)

Published in J Thromb Haemost on September 01, 2005

Authors

E J Kemp, L Strain, M L Diaz-Torres, J A Goodship, T H J Goodship

Articles citing this

Atypical Hemolytic Uremic Syndrome and Chronic Ulcerative Colitis Treated with Eculizumab. Int J Med Pharm Case Reports (2015) 0.75

Articles by these authors

Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet (1997) 6.85

Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus. Lancet (1992) 4.07

Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int (1998) 4.03

Factor H mutations in hemolytic uremic syndrome cluster in exons 18-20, a domain important for host cell recognition. Am J Hum Genet (2001) 2.92

The human GNAS1 gene is imprinted and encodes distinct paternally and biallelically expressed G proteins. Proc Natl Acad Sci U S A (1998) 2.50

Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins. Proc Natl Acad Sci U S A (1998) 2.41

Deletions within chromosome 22q11 in familial congenital heart disease. Lancet (1992) 2.29

A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet (1992) 2.23

Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet (2000) 1.92

Centiles for adult head circumference. Arch Dis Child (1992) 1.71

Identification of a mutation in synapsin I, a synaptic vesicle protein, in a family with epilepsy. J Med Genet (2004) 1.63

The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts. J Med Genet (2005) 1.59

Prevalence of tetracycline resistance genes in oral bacteria. Antimicrob Agents Chemother (2003) 1.59

DiGeorge syndrome with isolated aortic coarctation and isolated ventricular septal defect in three sibs with a 22q11 deletion of maternal origin. Br Heart J (1991) 1.46

Heterogeneity analysis in 40 X-linked retinitis pigmentosa families. Am J Hum Genet (1994) 1.38

Favorable long-term outcome after liver-kidney transplant for recurrent hemolytic uremic syndrome associated with a factor H mutation. Am J Transplant (2006) 1.37

A novel atypical 22q11.2 distal deletion in father and son. J Med Genet (2002) 1.27

Keratosis follicularis spinulosa decalvans: confirmation of linkage to Xp22.13-p22.2. J Med Genet (1998) 1.27

Cyclophosphamide treatment of mouse systemic lupus erythematosus. Lab Invest (1969) 1.25

Primary, nonsyndromic vesicoureteric reflux and its nephropathy is genetically heterogeneous, with a locus on chromosome 1. Am J Hum Genet (2000) 1.18

The normal population distribution of PRNP codon 129 polymorphism. Acta Neurol Scand (2003) 1.13

Maternal uniparental disomy for chromosome 2 in association with confined placental mosaicism for trisomy 2 and severe intrauterine growth retardation. Prenat Diagn (1996) 1.10

Effect of diet on survival and nephropathy of NZB-NZW hybrid mice. Biochem Med (1973) 1.04

Mutations in CHD7 in patients with CHARGE syndrome cause T-B + natural killer cell + severe combined immune deficiency and may cause Omenn-like syndrome. Clin Exp Immunol (2008) 1.02

A novel tissue inhibitor of metalloproteinases-3 mutation reveals a common molecular phenotype in Sorsby's fundus dystrophy. J Biol Chem (2000) 1.01

FISH mapping of de novo apparently balanced chromosome rearrangements identifies characteristics associated with phenotypic abnormality. Am J Hum Genet (2008) 0.96

Small inclusions in the cytoplasm of leukocytes in LE cell tests. J Rheumatol (1978) 0.95

Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy. Neuromuscul Disord (1993) 0.95

Population screening for fragile-X syndrome. Lancet (1993) 0.94

Characterization of TH1 and CTSZ, two non-imprinted genes downstream of GNAS1 in chromosome 20q13. Hum Genet (2000) 0.93

Familial relapsing haemolytic uraemic syndrome and complement factor H deficiency. Nephrol Dial Transplant (1999) 0.92

Confirmation of prenatal diagnosis of cystic fibrosis by DNA typing of fetal tissues. J Med Genet (1988) 0.90

Successful renal transplantation in factor H autoantibody associated HUS with CFHR1 and 3 deficiency and CFH variant G2850T. Am J Transplant (2009) 0.88

Evc regulates a symmetrical response to Shh signaling in molar development. J Dent Res (2013) 0.88

Successful isolated liver transplantation in a child with atypical hemolytic uremic syndrome and a mutation in complement factor H. Am J Transplant (2010) 0.87

The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation. Mol Immunol (2007) 0.87

Genetic basis of erythromycin resistance in oral bacteria. Antimicrob Agents Chemother (2004) 0.86

Factor H--US? Nephrol Dial Transplant (1998) 0.85

Structure and mutation analysis of the gene encoding DNA fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor gene. Hum Genet (2000) 0.85

Maternal uniparental heterodisomy for chromosome 2: detection through 'atypical' maternal AFP/hCG levels, with an update on a previous case. Prenat Diagn (2001) 0.84

Another case of maternal uniparental disomy chromosome 14 syndrome. Am J Med Genet (1997) 0.84

Bases adjacent to mononucleotide repeats show an increased single nucleotide polymorphism frequency in the human genome. Bioinformatics (2011) 0.83

Dilated cardiomyopathy, sudden cardiac death, hypoplastic discs, and retinal detachment: a new autosomal dominant syndrome. J Med Genet (2002) 0.83

Absence of mutations in the regulatory domain of the gap junction protein connexin 43 in patients with visceroatrial heterotaxy. Heart (1997) 0.82

Neurogenic chronic idiopathic intestinal pseudo-obstruction, patent ductus arteriosus, and thrombocytopenia segregating as an X linked recessive disorder. J Med Genet (1997) 0.82

Platelet-density analysis and intraplatelet granule content in young insulin-dependent diabetics. Diabetes (1986) 0.81

Discordant segregation of Xq28 markers and a mutation in the L1 gene in a family with X linked hydrocephalus. J Med Genet (1996) 0.81

Complement polymorphisms: geographical distribution and relevance to disease. Immunobiology (2011) 0.80

Sodium bicarbonate treatment and ubiquitin gene expression in acidotic human subjects with chronic renal failure. Eur J Clin Invest (2002) 0.80

Fragile X syndrome with FMR1 and FMR2 deletion. J Med Genet (1999) 0.79

Postpartum aHUS secondary to a genetic abnormality in factor H acquired through liver transplantation. Am J Transplant (2012) 0.79

L.E. cells after oral contraceptives. Lancet (1968) 0.78

Three new polymorphisms in the human complement factor H gene and promoter region. Immunogenetics (1997) 0.78

Ellis-van Creveld syndrome resulting from segmental uniparental disomy of chromosome 4. J Med Genet (2001) 0.77

Inherited prion disease with A117V mutation of the prion protein gene: a novel Hungarian family. J Neurol Neurosurg Psychiatry (2001) 0.76

Failure of procainamide to induce a systemic lupus erythematosus-like disease in animals. Toxicol Appl Pharmacol (1972) 0.76

Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome-A pedigree revisited. Mol Immunol (2010) 0.76

Effect of insulin upon protein degradation in cultured human myocytes. Eur J Clin Invest (2003) 0.76

Prenatal diagnosis of X-linked hydrocephalus. Prenat Diagn (1994) 0.76

Risk calculation in retinitis pigmentosa. Am J Hum Genet (1991) 0.75

Trisomy 12 mosaicism in a 7 year old girl with dysmorphic features and normal mental development. J Med Genet (1994) 0.75

von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med (1999) 0.75

A newly recognized, likely autosomal recessive syndrome comprising agammaglobulinemia, microcephaly, craniosynostosis, severe dermatitis, and other features. Am J Med Genet A (2006) 0.75

Comparison of LE cell tests. JAMA (1973) 0.75

Prenatal diagnosis of cystic fibrosis where single affected child has died: Guthrie spots and microvillar enzyme testing. Lancet (1988) 0.75

Is decreased treatment time in hemodialysis patients harmful if solute clearance is maintained? Int J Artif Organs (2002) 0.75

Monogenic diabetes, renal dysplasia and hypopituitarism: a patient with a HNF1A mutation. QJM (2010) 0.75

Reliability of a single beta-thromboglobulin measurement in a diabetic population: importance of PGE1 in anticoagulant mixture. Damad Study Group. Thromb Haemost (1987) 0.75

Prenatal detection of multiple copies of a familial supernumerary marker chromosome. Prenat Diagn (1992) 0.75

UFD1L is not the monogenic basis for heart defects associated with the CATCH phenotype. Mol Med Today (2000) 0.75

Genotyping of cystic fibrosis families with linked DNA probes. Clin Genet (1988) 0.75

Letter: SLE latex test kit. JAMA (1974) 0.75

First-trimester prenatal diagnosis of cystic fibrosis using fibroblasts from a deceased index child to establish haplotypes. Prenat Diagn (1988) 0.75